var data={"title":"Framycetin, gramicidin, and dexamethasone (United States: Not available): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Framycetin, gramicidin, and dexamethasone (United States: Not available): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/44130?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=framycetin-gramicidin-and-dexamethasone-united-states-not-available-patient-drug-information\" class=\"drug drug_patient\">see &quot;Framycetin, gramicidin, and dexamethasone (United States: Not available): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620911\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Sofracort</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620912\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Anti-inflammatory Agent, Ophthalmic;</li>\n      <li>\n        Antibiotic, Ophthalmic;</li>\n      <li>\n        Antibiotic, Otic;</li>\n      <li>\n        Corticosteroid, Ophthalmic;</li>\n      <li>\n        Corticosteroid, Otic</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622196\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ophthalmic infections/inflammation: </b>Ophthalmic:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Drops: Acute conditions: 1 or 2 drops in affected eye(s) every 1 to 2 hours usually for 2 or 3 days, then follow with 1 or 2 drops 3 to 4 times daily.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Apply to affected eye(s) 2 or 3 times daily (may apply as single dose at bedtime if drops have been used during the day).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Otic infections/inflammation: </b>Otic:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Drops: 2 or 3 drops in affected ear(s) 3 or 4 times daily.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Apply to outer portion of and inside the ear canal and adjacent infected areas 2 or 3 times daily, including bedtime.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50990603\" class=\"block dora drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment (Adult)</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50987584\" class=\"block doha drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment (Adult)</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622197\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45623674\" class=\"block foccan drugH1Div\"><span class=\"drugH1\">Dosage Forms: Canada</span>\n    <p style=\"text-indent:0em;display:inline\">Information with regard to form, strength, and availability of products uniquely available in Canada but currently not available in the US. Refer also to Dosage forms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ointment, Ophthalmic/Otic:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Sofracort: Framycetin sulphate 5 mg, gramicidin 0.05 mg, and dexamethasone 0.5 mg per 1 g</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, Ophthalmic/Otic:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Sofracort: Framycetin sulphate 5 mg, gramicidin 0.05 mg, and dexamethasone 0.5 mg per 1 mL</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622212\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Not available in the US</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622205\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ophthalmic: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Drops: Do not touch tip of container to eye or other surfaces.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Do not touch tip of tube to eye. Instill ointment into pocket between eyeball and lower lid; close treated eye(s) for 1 to 2 minutes and roll eyeball around.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Otic: <b>Note:</b> Otic preparations should not be used when the integrity of the tympanic membrane is in question (Rosenfeld [AAP 2014]).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Drops: Do not touch ear with dropper. Patient should lie down with affected ear upward. This position should be maintained for 5 minutes after the drops have been instilled to facilitate penetration. Repeat, if necessary, for the opposite ear. If preferred, a saturated gauze wick may be inserted by the healthcare provider into the canal. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ointment: Apply ointment to outer portion of, and inside the ear canal and to surrounding infected areas.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620914\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ophthalmic infections/inflammation: </b>Treatment of the following conditions: blepharitis and infected eczema of the eyelid; allergic, infective and rosacea conjunctivitis; rosacea keratitis; scleritis and episcleritis; iridocyclitis; other inflammatory conditions of the anterior segment of the eye</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Otic infections/inflammation:</b> Treatment of otitis externa (acute and chronic) and other inflammatory and sebhorrheic conditions of the external ear</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45638043\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined. See individual agents for additional adverse reactions.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity: Hypersensitivity</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ophthalmic: Burning sensation of eyes, corneal perforation, increased intraocular pressure, stinging of eyes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620917\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ophthalmic use: Hypersensitivity to any component of the formulation; herpes simplex and other viral diseases of the cornea and conjunctiva; tuberculosis and fungal disease of the eye; trachoma; acute purulent, untreated ocular infections which may be masked or enhanced by the presence of a steroid</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Otic use: Hypersensitivity to any component of the formulation; viral and fungal infections; acute purulent, untreated infections; perforation of the eardrum</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622177\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Adrenal suppression: Systemic absorption of topical corticosteroids may cause hypercortisolism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Immunosuppression: Prolonged use may increase the hazard of secondary ocular infections. May mask infection or enhance existing infection. The possibility of persistent corneal fungal infection should be considered after prolonged use. Corticosteroids should not be used to treat ocular herpes simplex; use caution in patients with a history of ocular herpes simplex; reactivation of viral infection may occur.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Ocular effects: Avoid prolonged use, which may result in ocular hypertension and/or glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision, and posterior subcapsular cataract formation. Monitor intraocular pressure with prolonged use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Ocular disease: Perforations may occur in diseases which cause thinning of the cornea or sclera.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45525247\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45525244\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=105437&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Ceritinib: Corticosteroids may enhance the hyperglycemic effect of Ceritinib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CYP3A4 Inhibitors (Strong): May increase the serum concentration of Dexamethasone (Ophthalmic).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Nonsteroidal Anti-Inflammatory Agents (Ophthalmic): May enhance the adverse/toxic effect of Corticosteroids (Ophthalmic). Healing of ophthalmic tissue during concomitant administration of ophthalmic products may be delayed.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ritodrine: Corticosteroids may enhance the adverse/toxic effect of Ritodrine. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620915\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to Dexamethasone (Ophthalmic) monograph.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45620916\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to Dexamethasone (Ophthalmic) monograph.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622211\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Intraocular pressure (with prolonged ophthalmic use)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45622186\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Framycetin is a broad spectrum aminoglycoside antibiotic that is usually bactericidal; appears to inhibit protein synthesis in susceptible bacteria by binding ribosomal subunits. Active against many aerobic gram-negative organisms and some aerobic gram-positive organisms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gramicidin is a cyclic polypeptide antibiotic that alters the cation content of the bacterial cell wall; primarily effective against gram-positive organisms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dexamethasone decreases inflammation by suppression of neutrophil migration, decreased production of inflammatory mediators, and reversal of increased capillary permeability; suppresses normal immune response.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45649726\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Blecidex (ID);</li>\n      <li>Fradex (PK);</li>\n      <li>Otodex Ear Drops (AU);</li>\n      <li>Sofracort (IN);</li>\n      <li>Sofradex (DK, EG, GB, HK, ID, IE, IS, KW, LB, MT, MY, NL, NO, QA, RU, SE, SG, TH, ZA);</li>\n      <li>Sofradex Ear Drops (AU);</li>\n      <li>Sofradex Ear/Eye Drops (NZ)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. <i>Otolaryngol Head Neck Surg</i>. 2014;150(1 suppl):S1-S24. doi: 10.1177/0194599813517083<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/framycetin-gramicidin-and-dexamethasone-united-states-not-available-drug-information/abstract-text/24491310/pubmed\" target=\"_blank\" id=\"24491310\">24491310</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sofracort (framycetin sulphate, gramicidin, dexamethasone) [product monograph]. Laval, Quebec, Canada: Sanofi-aventis Canada Inc; April 2006.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 105437 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F45620911\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F45620912\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F45622196\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment (Adult)\" href=\"#F50990603\" class=\"outlineLink\">Dosing: Renal Impairment (Adult)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment (Adult)\" href=\"#F50987584\" class=\"outlineLink\">Dosing: Hepatic Impairment (Adult)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F45622197\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms: Canada\" href=\"#F45623674\" class=\"outlineLink\">Dosage Forms: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F45622212\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F45622205\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F45620914\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F45638043\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F45620917\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F45622177\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F45525247\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F45525244\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F45620915\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F45620916\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F45622211\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F45622186\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F45649726\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/105437|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=framycetin-gramicidin-and-dexamethasone-united-states-not-available-patient-drug-information\" class=\"drug drug_patient\">Framycetin, gramicidin, and dexamethasone (United States: Not available): Patient drug information</a></li></ul></div></div>","javascript":null}